MENU
+Compare
HQL
ETF ticker: NYSE
AS OF
Jul 25 closing price
Price
$13.33
Change
-$0.00 (-0.00%)
Net Assets
434.08M

HQL stock forecast, quote, news & analysis

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company... Show more

HQL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for HQL with price predictions
Jul 25, 2025

Aroon Indicator for HQL shows an upward move is likely

HQL's Aroon Indicator triggered a bullish signal on July 25, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 240 similar instances where the Aroon Indicator showed a similar pattern. In of the 240 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 25, 2025. You may want to consider a long position or call options on HQL as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for HQL just turned positive on July 23, 2025. Looking at past instances where HQL's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HQL advanced for three days, in of 315 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for HQL moved out of overbought territory on July 11, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

HQL broke above its upper Bollinger Band on July 18, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Industry description

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.

Volume

The average weekly volume growth across all stocks in the abrdn Life Sciences Investors ETF was -2%. For the same stocks of the ETF, the average monthly volume growth was -2% and the average quarterly volume growth was -30%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 79
Price Growth Rating: 49
SMR Rating: 66
Profit Risk Rating: 63
Seasonality Score: -7 (-100 ... +100)
View a ticker or compare two or three
HQL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Unknown

Profile
Fundamentals
Details
Category
Health
Address
2 Liberty Square9th FloorBoston
Phone
N/A
Web
https://www.teklacap.com/funds/hql/fund/fund-information/